Testosterone replacement study for adolescent boys with low testosterone
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a testosterone injection (XYOSTED) to see if it's safe and effective for replacing testosterone in teenage boys who have low levels due to a known medical condition. It lasts 52 weeks, with an optional 2-year follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a boy between 12 and 18 years old.
- You must have a diagnosis of low testosterone caused by a known medical problem.
- If you've used testosterone before, the dose must have been steady for at least 12 weeks. If you've never used it, that's okay.
- Your parent or legal guardian must agree to the study, and you must be willing to participate.
- You must weigh at least 30 kilograms (about 66 pounds) and have a body mass index above the 5th percentile for your age.
- If you are sexually active with a female partner, you must agree to use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how testosterone therapy affects blood pressure over 24 hours in men with low testosterone. It may help you understand how this treatment could affect your heart health.
This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are under active surveillance. It aims to see if treatment can help without worsening the cancer.
This Phase 2 study tests whether testosterone therapy can help men with chronic kidney disease who have low testosterone and related symptoms. It looks to see if treatment is safe and beneficial, while carefully checking heart, blood, prostate, and clotting risks.
This study tests whether a special diet can improve symptoms of low testosterone in men. It is intended to help men with certain symptoms like a low sex drive or trouble having erections and whose blood tests show low to borderline testosterone levels.
This trial tests if a new weekly growth hormone shot (somatrogon) works as well as a daily one (Genotropin) for children who are short because they were born small or have no clear cause.
This trial tests an experimental medicine for teenage boys with a condition called hypogonadotropic hypogonadism, where the body doesn't make enough sex hormones. The treatment combines two hormone-based injections to help the testes grow and function, with a goal of improving puberty.
Hear when a new Hypogonadism, Male trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.